Clinical Trial Update: Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing whether fostamatinib alters the blood concentrations of pioglitazone in healthy subjects to evaluate potential drug-drug interaction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fostamatinib (fostamatinib)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis, Healthy Volunteers | Phase 1 | Status: COMPLETED